Gsa Capital Partners LLP Ampio Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$0.39 - $0.7 $218,200 - $391,642	-559,489 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$0.43 - $0.68 $45,703 - $72,275	-106,287 Reduced 15.96%	559,489 $314,000
Q4 2018 Feb 12, 2019	BUY	$0.39 - $0.7 $259,652 - $466,043	665,776 New	665,776 $263,000
Q3 2018 Nov 13, 2018	SELL	$0.44 - $3.02 $9,866 - $67,717	-22,423 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$1.66 - $3.82 $37,222 - $85,655	22,423 New	22,423 $49,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.